Robert E. Waltermire - Net Worth and Insider Trading
Robert E. Waltermire Net Worth
The estimated net worth of Robert E. Waltermire is at least $1 Million dollars as of 2024-05-02. Robert E. Waltermire is the Senior VP, Chief Pharma Dev. of Madrigal Pharmaceuticals Inc and owns about 5,667 shares of Madrigal Pharmaceuticals Inc (MDGL) stock worth over $1 Million. Details can be seen in Robert E. Waltermire's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert E. Waltermire has not made any transactions after 2023-12-15 and currently still holds the listed stock(s).
Transaction Summary of Robert E. Waltermire
Robert E. Waltermire Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert E. Waltermire owns 1 companies in total, including Madrigal Pharmaceuticals Inc (MDGL) .
Click here to see the complete history of Robert E. Waltermire’s form 4 insider trades.
Insider Ownership Summary of Robert E. Waltermire
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MDGL | Madrigal Pharmaceuticals Inc | 2023-12-15 | Senior VP & Chief Pharma Dev. |
Robert E. Waltermire Latest Holdings Summary
Robert E. Waltermire currently owns a total of 1 stock. Robert E. Waltermire owns 5,667 shares of Madrigal Pharmaceuticals Inc (MDGL) as of December 15, 2023, with a value of $1 Million.
Latest Holdings of Robert E. Waltermire
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MDGL | Madrigal Pharmaceuticals Inc | 2023-12-15 | 5,667 | 214.20 | 1,213,871 |
Holding Weightings of Robert E. Waltermire
Robert E. Waltermire Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert E. Waltermire has made a total of 2 transactions in Madrigal Pharmaceuticals Inc (MDGL) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Madrigal Pharmaceuticals Inc is the sale of 4,000 shares on December 15, 2023, which brought Robert E. Waltermire around $942,000.
Insider Trading History of Robert E. Waltermire
- 1
Robert E. Waltermire Trading Performance
Robert E. Waltermire Ownership Network
Robert E. Waltermire Owned Company Details
What does Madrigal Pharmaceuticals Inc do?
Who are the key executives at Madrigal Pharmaceuticals Inc?
Robert E. Waltermire is the Senior VP & Chief Pharma Dev. of Madrigal Pharmaceuticals Inc. Other key executives at Madrigal Pharmaceuticals Inc include director & Chief Executive Officer Paul A Friedman , director & Chief Medical Officer & EVP R&D Rebecca Taub , and SVP and General Counsel Brian Joseph Lynch .
Madrigal Pharmaceuticals Inc (MDGL) Insider Trades Summary
Over the past 18 months, Robert E. Waltermire made 2 insider transaction in Madrigal Pharmaceuticals Inc (MDGL) with a net sale of 7,800. Other recent insider transactions involving Madrigal Pharmaceuticals Inc (MDGL) include a net purchase of 424,685 shares made by Baker Bros. Advisors Lp , a net sale of 29,800 shares made by Brian Joseph Lynch , and a net sale of 100,000 shares made by Paul A Friedman .
In summary, during the past 3 months, insiders sold 252,542 shares of Madrigal Pharmaceuticals Inc (MDGL) in total and bought 0 shares, with a net sale of 252,542 shares. During the past 18 months, 342,631 shares of Madrigal Pharmaceuticals Inc (MDGL) were sold and 424,685 shares were bought by its insiders, resulting in a net purchase of 82,054 shares.
Madrigal Pharmaceuticals Inc (MDGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Madrigal Pharmaceuticals Inc Insider Transactions
Robert E. Waltermire Mailing Address
Above is the net worth, insider trading, and ownership report for Robert E. Waltermire. You might contact Robert E. Waltermire via mailing address: Four Tower Bridge, 200 Barr Harbor Drive, Suite 200, West Conshohocken Pa 19428.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
